Works matching DE "PATHOLOGIC complete response"

Results: 416
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical Cystectomy.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 9, p. 1, doi. 10.1002/cam4.70782
    By:
    • Hatakeyama, Shingo;
    • Taoka, Rikiya;
    • Miki, Jun;
    • Saito, Ryoichi;
    • Fukuokaya, Wataru;
    • Matsui, Yoshiyuki;
    • Kawahara, Takashi;
    • Matsuda, Ayumu;
    • Kawai, Taketo;
    • Kato, Minoru;
    • Sazuka, Tomokazu;
    • Sano, Takeshi;
    • Urabe, Fumihiko;
    • Kashima, Soki;
    • Naito, Hirohito;
    • Murakami, Yoji;
    • Miyake, Makito;
    • Daizumoto, Kei;
    • Matsushita, Yuto;
    • Hayashi, Takuji
    Publication type:
    Article
    14
    15
    16
    17
    18
    19

    The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14252-3
    By:
    • Yıldırım, Sedat;
    • Başoğlu, Tugba;
    • Doğan, Akif;
    • Akdağ, Goncagul;
    • Kınıkoğlu, Oguzcan;
    • Topal, Alper;
    • Alan, Ozkan;
    • Solmaz, Ali Alper;
    • Gürbüz, Mustafa;
    • Çil, Timucin;
    • Çolak, Rumeysa;
    • Yılmaz, Mesut;
    • Kalem, Ali;
    • Sever, Nadiye;
    • Majıdova, Nargiz;
    • Karakoyun, Kubilay;
    • Sekmek, Serhat;
    • Saçlı, Omer;
    • Ozcelık, Melike;
    • Işık, Deniz
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45591-7
    By:
    • Huang, Liang;
    • Pang, Da;
    • Yang, Hongjian;
    • Li, Wei;
    • Wang, Shusen;
    • Cui, Shude;
    • Liao, Ning;
    • Wang, Yongsheng;
    • Wang, Chuan;
    • Chang, Yuan-Ching;
    • Wang, Hwei-Chung;
    • Kang, Seok Yun;
    • Seo, Jae Hong;
    • Shen, Kunwei;
    • Laohawiriyakamol, Suphawat;
    • Jiang, Zefei;
    • Wang, Haiyan;
    • Lamour, François;
    • Song, Grace;
    • Curran, Michelle
    Publication type:
    Article
    36
    37
    38

    Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

    Published in:
    Cancers, 2025, v. 17, n. 6, p. 966, doi. 10.3390/cancers17060966
    By:
    • Xu, Zhan;
    • Zhou, Zijian;
    • Son, Jong Bum;
    • Feng, Haonan;
    • Adrada, Beatriz E.;
    • Moseley, Tanya W.;
    • Candelaria, Rosalind P.;
    • Guirguis, Mary S.;
    • Patel, Miral M.;
    • Whitman, Gary J.;
    • Leung, Jessica W. T.;
    • Le-Petross, Huong T. C.;
    • Mohamed, Rania M.;
    • Panthi, Bikash;
    • Lane, Deanna L.;
    • Chen, Huiqin;
    • Wei, Peng;
    • Tripathy, Debu;
    • Litton, Jennifer K.;
    • Valero, Vicente
    Publication type:
    Article
    39
    40
    41
    42
    43

    A Comprehensive Analysis of Neoadjuvant Chemotherapy in Breast Cancer: Adverse Events, Clinical Response Rates, and Surgical and Pathological Outcomes—Bozyaka Experience.

    Published in:
    Cancers, 2025, v. 17, n. 2, p. 163, doi. 10.3390/cancers17020163
    By:
    • Yılmaz, Cengiz;
    • Zengel, Baha;
    • Üreyen, Orhan;
    • Adıbelli, Zehra Hilal;
    • Taşlı, Funda;
    • Yılmaz, Hasan Taylan;
    • Özdemir, Özlem;
    • Kocatepe Çavdar, Demet;
    • Mollamehmetoğlu, Hülya;
    • Çakıroğlu, Umut;
    • İmren, Yaşar;
    • Yakan, Savaş;
    • İlhan, Enver
    Publication type:
    Article
    44

    Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial).

    Published in:
    Cancers, 2024, v. 16, n. 24, p. 4173, doi. 10.3390/cancers16244173
    By:
    • Mögele, Tatiana;
    • Höck, Michael;
    • Sommer, Florian;
    • Friedrich, Lena;
    • Sommer, Sebastian;
    • Schmutz, Maximilian;
    • Altenburger, Amadeus;
    • Messmann, Helmut;
    • Anthuber, Matthias;
    • Kröncke, Thomas;
    • Stüben, Georg;
    • Trepel, Martin;
    • Märkl, Bruno;
    • Dintner, Sebastian;
    • Claus, Rainer
    Publication type:
    Article
    45

    Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

    Published in:
    Cancers, 2024, v. 16, n. 23, p. 4104, doi. 10.3390/cancers16234104
    By:
    • Krasniqi, Eriseld;
    • Filomeno, Lorena;
    • Arcuri, Teresa;
    • Di Lisa, Francesca Sofia;
    • Astone, Antonio;
    • Cutigni, Claudia;
    • Foglietta, Jennifer;
    • Nunzi, Martina;
    • Rossi, Rosalinda;
    • Minelli, Mauro;
    • Meattini, Icro;
    • Visani, Luca;
    • Scialino, Jacopo;
    • Livi, Lorenzo;
    • Moscetti, Luca;
    • Marchetti, Paolo;
    • Botticelli, Andrea;
    • Paris, Ida;
    • Pavese, Francesco;
    • D'Angelo, Tatiana
    Publication type:
    Article
    46
    47
    48
    49

    Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study.

    Published in:
    Cancers, 2024, v. 16, n. 19, p. 3389, doi. 10.3390/cancers16193389
    By:
    • Karci, Ebru;
    • Bilici, Ahmet;
    • Bayram, Buket;
    • Celayir, Melisa;
    • Ozyurt, Neslihan;
    • Uluc, Başak Oyan;
    • Eken, Aynur;
    • Basaran, Gul;
    • Demirci, Umut;
    • Kemal, Yasemin;
    • Oruncu, Mehmet Berk;
    • Olmez, Omer Fatih;
    • Selcukbiricik, Fatih;
    • Korkmaz, Taner;
    • Erturk, Ismail;
    • Bilgetekin, Irem;
    • Celik, Serkan;
    • Turkel, Alper;
    • Alkan, Ali;
    • Sakin, Abdullah
    Publication type:
    Article
    50